FDA label 7be0f873-313b-4592-bfb6-fa5ce0c3ea78

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
b20fbfdd-c878-43af-ac86-1102385809ca
SPL ID
7be0f873-313b-4592-bfb6-fa5ce0c3ea78
Version
4
Effective date
2017-10-17
Source export date
2026-09-28
Source partition
5
Source file
https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/9839785a692b692224cd5f90f9e3a9514c9923a6f521ab83eed3bedc7c0e1d05/drug-label-0005-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:29:14

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS KEEP OUT OF REACH OF CHILDREN: It is important for patients to store and dispose of Adiposix BIOfrequency Chips out of the reach of children and pets. For external use only. Application to broken or infl amed skin, although not tested, may result in higher blood concentrations from increased absorption. Adiposix BIOfrequency Chip is only recommended for use on intact skin. The most common adverse reactions are application site reactions, including dermatitis, itching or scaling. These tend to be dose-limiting and diminish with time. Long-term safety is unknown. Pregnancy: the safety of Adiposix BIOfrequency Chip has not been established during pregnancy.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.